Surrogate cytokine agonists: promising agents against COVID-19

Zemin Lin¹, Jianping Zuo^{2

3

4}, Shijun He^{5

6}

Affiliations

¹ Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
² Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. jpzuo@simm.ac.cn.
³ University of Chinese Academy of Sciences, Beijing, 100049, China. jpzuo@simm.ac.cn.
⁴ Laboratory of Immunology and Virology, Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, 201203, China. jpzuo@simm.ac.cn.
⁵ Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. heshijun@simm.ac.cn.
⁶ University of Chinese Academy of Sciences, Beijing, 100049, China. heshijun@simm.ac.cn.

PMID: 35523768
PMCID: PMC9072766
DOI: 10.1038/s41392-022-01015-w

Free PMC article

Comment

Surrogate cytokine agonists: promising agents against COVID-19

Zemin Lin et al. Signal Transduct Target Ther. 2022.

Free PMC article

. 2022 May 6;7(1):150.

doi: 10.1038/s41392-022-01015-w.

Authors

Zemin Lin¹, Jianping Zuo^{2

3

4}, Shijun He^{5

6}

Affiliations

¹ Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
² Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. jpzuo@simm.ac.cn.
³ University of Chinese Academy of Sciences, Beijing, 100049, China. jpzuo@simm.ac.cn.
⁴ Laboratory of Immunology and Virology, Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, 201203, China. jpzuo@simm.ac.cn.
⁵ Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. heshijun@simm.ac.cn.
⁶ University of Chinese Academy of Sciences, Beijing, 100049, China. heshijun@simm.ac.cn.

PMID: 35523768
PMCID: PMC9072766
DOI: 10.1038/s41392-022-01015-w

No abstract available

PubMed Disclaimer

Comment on

Facile discovery of surrogate cytokine agonists.
Yen M, Ren J, Liu Q, Glassman CR, Sheahan TP, Picton LK, Moreira FR, Rustagi A, Jude KM, Zhao X, Blish CA, Baric RS, Su LL, Garcia KC. Yen M, et al. Cell. 2022 Apr 14;185(8):1414-1430.e19. doi: 10.1016/j.cell.2022.02.025. Epub 2022 Mar 23. Cell. 2022. PMID: 35325595 Free PMC article.

References

1. Signal Transduct Target Ther. 2022 Jan 27;7(1):26 - PubMed
1. Cell. 2022 Apr 14;185(8):1414-1430.e19 - PubMed
1. Sci Immunol. 2022 Jan 07;7(67):eabm5505 - PubMed
1. Nat Immunol. 2022 Apr;23(4):478-480 - PubMed
1. Science. 2022 Apr 8;376(6589):163-169 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Surrogate cytokine agonists: promising agents against COVID-19

Affiliations

Surrogate cytokine agonists: promising agents against COVID-19

Authors

Affiliations

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources